Saturday, July 11, 2026

Drug profile · INN

human protein c

human protein c (CEPROTIN) is a vitamin k-dependent protein c exogenous protein. Associated with Takeda.

EMA: approved Blood and blood forming organs (B01) B01AD12
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — human protein c
Class
Blood and blood forming organs (B01)
Route
Patents
0
Programs
0
Data quality
0.89

Quick answer

human protein c (CEPROTIN) is a vitamin k-dependent protein c exogenous protein. Associated with Takeda.

Key facts

INN human protein c
Brand CEPROTIN
Mechanism Vitamin K-dependent protein C exogenous protein
Target Vitamin K-dependent protein C
Therapeutic class Blood and blood forming organs (B01)
ATC code B01AD12
Originator Takeda

Mechanism of action

Vitamin K-dependent protein C exogenous protein

Primary target: Vitamin K-dependent protein C

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. apixaban Blood and blood forming organs (B01)
  2. berotralstat Blood and blood forming organs (B06)
  3. bivalirudin Blood and blood forming organs (B01)
  4. c1 inhibitor (human) Blood and blood forming organs (B06)
  5. clopidogrel Blood and blood forming organs (B01)
  6. dabigatran etexilate Blood and blood forming organs (B01)

Frequently asked questions

What is human protein c?

human protein c (CEPROTIN) is a vitamin k-dependent protein c exogenous protein. Associated with Takeda.

What is the brand name for human protein c?

CEPROTIN is a marketed brand name for human protein c. Check FDA Drugs@FDA for the current US label holder and prescribing information.